{{Rsnum
|rsid=2444896
|Gene=MATN2
|Chromosome=8
|position=98009781
|Orientation=plus
|GMAF=0.2553
|Gene_s=MATN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 63.7 | 32.7 | 3.5
| HCB | 55.9 | 37.5 | 6.6
| JPT | 49.6 | 40.7 | 9.7
| YRI | 70.7 | 27.2 | 2.0
| ASW | 54.4 | 42.1 | 3.5
| CHB | 55.9 | 37.5 | 6.6
| CHD | 43.1 | 50.5 | 6.4
| GIH | 34.7 | 50.5 | 14.9
| LWK | 70.0 | 28.2 | 1.8
| MEX | 34.5 | 51.7 | 13.8
| MKK | 60.9 | 35.9 | 3.2
| TSI | 63.7 | 31.4 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=2E-6
  |OR=1.75
  |ORtxt=[1.355-2.269]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}